{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/242628516"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "In addition, the Company and Aurinia have negotiated a tripartite settlement with ILJIN Life Science Co., Ltd. (ILJIN) pursuant to which, upon the successful completion of the proposed merger, the combined company will re-acquire full rights to voclosporin for autoimmune indications including lupus, and transplantation in the United States, Europe and other regions of the world, outside of Canad" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "globenewswire.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/387598922"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/242628516"] } } }
